HCPCS Level IIdrugActive
J1555
Inj cuvitru, 100 mg
BETOS: D1G
Effective: 2018-01-01
Referenced in 4 policies
Description
Injection, immune globulin (cuvitru), 100 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Cuvitru
Manufacturer
Takeda Pharmaceuticals America, Inc.
HCPCS Dosage
100 MG
Billing Units
10.0000
5
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.